Ticker
KALVCompany Name
KALVISTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Yield | Market Capitalization | Net Income Common Stock |
---|---|---|---|
6/30/2025 | -27.14% | $ 748.25M | $ -203.1M |
3/31/2025 | -23.68% | $ 774.78M | $ -183.44M |
12/31/2024 | -28.41% | $ 618.96M | $ -175.87M |
9/30/2024 | -34.95% | $ 447.48M | $ -156.39M |
6/30/2024 | -25.49% | $ 556.18M | $ -141.77M |
3/31/2024 | -23.71% | $ 534.2M | $ -126.64M |
12/31/2023 | -19.6% | $ 552.67M | $ -108.3M |
9/30/2023 | -32.44% | $ 309.99M | $ -100.58M |
6/30/2023 | -25.52% | $ 372.93M | $ -95.18M |
3/31/2023 | -25.92% | $ 358.43M | $ -92.91M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Market Cap
(=) Earnings Yield
Earnings Yield for KALVISTA PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -37.12M ] / Market Cap [ $ 314.53M ]
(=) Earnings Yield [ -11.8% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.42K |
---|---|
min | -31.79% |
max | 32.87% |
average | 0.33% |
median | 2.78% |
std | 9.82% |